Compare AbCellera Biologics Inc (ABCL) vs Braze Inc (BRZE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Braze Inc — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Braze Inc trades at $28.06 (market cap $3.18B). The key difference: AbCellera Biologics Inc and Braze Inc are close in size by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Braze Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | BRZE | |
|---|---|---|
Market Cap | $2.99B | $3.18B |
Sector | Health | Technology |
52-Week High | $9.76 | $36.19 |
52-Week Low | $2.78 | $15.79 |
Enterprise Value | $2.58B | $2.87B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Braze Inc
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries.
Read more on BRZE →
